Holding(s) in Company
Oxford Technology 2 VCT Plc has notified Arecor Therapeutics PLC of a change in its major holding, with its voting rights decreasing from 4.21% to 3.51%, representing 1,587,776 voting rights. This change, which occurred on October 6, 2026, was reported to the issuer on October 12, 2026. The notification indicates an event changing the breakdown of voting rights, and Oxford Technology 2 VCT Plc is not controlled by any other entity.
Select text to share a quote on X · sign in to keep highlights & notes in your AREC notes
Non-UK issuer
- Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rights
An acquisition or disposal of financial instruments
| An event changing the breakdown of voting rights | X |
Other (please specify) iii :
Details of person subject to the notification obligation iv
| Name | Oxford Technology 2 VCT Plc |
| City and country of registered office (if applicable) | Oxford, UK |
Full name of shareholder(s) (if different from 3.) v
Name
City and country of registered office (if applicable)
| 5. Date on which the threshold was crossed or reached vi : | 06/10/26 |
| 6. Date on which issuer notified (DD/MM/YYYY): | 12/10/26 |
- Total positions of person(s) subject to the notification obligation
| % of voting rights attached to shares (total of 8. A) | % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) | Total of both in % (8.A + 8.B) | Total number of voting rights held in issuer (8.A + 8.B) vii | |
|---|---|---|---|---|
| Resulting situation on the date on which threshold was crossed or reached | 3.51 | 3.51 | 1,587,776 | |
| Position of previous notification (if applicable) | 4.21 | 4.21 | ||
| A: Voting rights attached to shares | ||||
| Class/type of shares ISIN code (if possible) | Number of voting rights ix | % of voting rights | ||
| Direct (DTR5.1) | Indirect (DTR5.2.1) | Direct (DTR5.1) | Indirect (DTR5.2.1) | |
| GB00BMWLM973 | 1,587,776 | 3.51 | ||
| SUBTOTAL 8. A | 1,587,776 | 3.51 | ||
| B 1: Financial Instruments according to DTR5.3.1R (1) (a) | ||||
| Type of financial instrument | Expiration date x | Exercise/ Conversion Period xi | Number of voting rights that may be acquired if the instrument is exercised/converted. | % of voting rights |
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
| Type of financial instrument | Expiration date x | Exercise/ Conversion Period xi | Physical or cash Settlement xii | Number of voting rights | % of voting rights |
| SUBTOTAL 8.B.2 | |||||
| Name xv | % of voting rights if it equals or is higher than the notifiable threshold | % of voting rights through financial instruments if it equals or is higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable threshold | ||
| 10. In case of proxy voting, please identify: | |||||
| Name of the proxy holder | n/a | ||||
| The number and % of voting rights held | n/a | ||||
| The date until which the voting rights will be held | n/a | ||||
| 11. Additional information xvi | |||||
| Place of completion | Oxford | ||||
| Date of completion | 12 October 2026 | ||||
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.